Deoratives Bannerbild

ESMO Breast Cancer Meeting


GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.

Visit us at booth No 20 and visit our presentations.

SASCIA - Oral presentation #58O
Date: Wed, 04.05.2022. Lecture time: 16:45
Session: Proffered Paper session 2
Chairs: G. Curigliano S. Delaloge S. Kim
Speakers: F. Marmé
Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment.
F. Marmé, C. Hanusch, J. Furlanetto, et al.

PenelopeB - Mini oral #60MO
Date: Tue, 03.05.2022. Lecture time: 16:22 - 16:29
Session: Mini Oral session 1
Chairs: L. Del Mastro P. Poortmans
Speakers: J. Furlanetto
Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): explorative analysis in Penelope-B
J. Furlanetto, F. Marmé, C. Thode, et al.

BMBC - Poster #170P
Date: Wed, 04.05.2022. Lecture Time: 12:15 - 13:00
Speakers: K. Riecke
Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC Registry
K. Riecke, E. Laakmann, T. Neunhöffer, et al.

GeparX - Poster #94P
Date: Wed, 04.05.2022. Lecture Time: 12:15 - 13:00
Speakers: M. Reinisch
Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)
M. Reinisch, J.-U. Blohmer, T. Link, et al.

GeparQuattro, GeparQuinto and GeparSixto - Poster #24P
Date: Wed, 04.05.2022
Lecture Time: 12:15 - 13:00
Speakers: B. Sinn
Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome
B. Sinn, M. Untch, T. Karn, et al.

ESMO Breast Cancer 3.-5. May 2022


GBG Forschungs GmbH
Dornhofstr. 10 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd